|[January 02, 2013]
Clovis Oncology to Present at the 31st Annual J.P. Morgan Healthcare Conference
BOULDER, Colo. --(Business Wire)--
Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that Patrick J.
Mahaffy, Chief Executive Officer and President of Clovis will present at
the 31st Annual J.P. Morgan Healthcare Conference on Tuesday,
January 8, 2012 at 9:00 AM Pacific Time. The conference will be held at
the Westin St. Francis Hotel in San Francisco, CA (News - Alert).
A live webcast of the presentation can be accessed through the investor
relations section of the Company's website at www.clovisoncology.com.
Following the live presentation, a replay of the webcast will be
available on the Company's website for 30 days.
About Clovis Oncology
Clovis Oncology, Inc. is a biopharmaceutical company focused on
acquiring, developing and commercializing innovative anti-cancer agents
in the U.S., Europe and additional international markets. Clovis
Oncology targets development programs at specific subsets of cancer
populations, and simultaneously develops diagnostic tools that direct a
compound in development to the population that is most likely to benefit
from its use. Clovis Oncology is headquartered in Boulder, Colorado, and
has additional offices in San Francisco, California and Cambridge, UK.
[ Back To TMCnet.com's Homepage ]